ED
HSIC icon

Exane Derivatives’s Henry Schein HSIC Stock Holding History

Exane Derivatives’s Portfolio HSIC Stock Details HSIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$77 Sell
1
-4,653
-100% -$390K ﹤0.01% 728
2022
Q1 		$406K Buy
4,654
+4,608
+10,017% +$375K 0.11% 214
2021
Q4 		$3.57K Sell
46
-5,215
-99% -$399K ﹤0.01% 631
2021
Q3 		$401K Buy
+5,261
New +$405K 0.1% 226

Other funds holding HSIC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exane Derivatives's HSIC Position: Q2 2022 in Review

Exane Derivatives reduced its Henry Schein (HSIC) stake by 100% in Q2 2022, selling an estimated $390K and leaving 1 share worth $77. The position accounts for ﹤0.01% of the portfolio, ranked #728.

Exane Derivatives first reported a position in HSIC in Q3 2021 and has held it in 4 quarters since. The position peaked at $406K in Q1 2022. 577 funds tracked by Wall St. Rank hold HSIC as of Q2 2022.

  • Exane Derivatives held 1 share of Henry Schein worth $77 as of Q2 2022.
  • Exane Derivatives sold 4,653 Henry Schein shares in Q2 2022, an estimated $390K.
  • Henry Schein made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #728 holding.
  • Exane Derivatives first reported a position in Henry Schein in Q3 2021 and has held it in 4 quarters since.
  • Exane Derivatives's Henry Schein position peaked at $406K in Q1 2022.
  • 577 funds tracked by Wall St. Rank held Henry Schein as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.